129 related articles for article (PubMed ID: 26910067)
1. In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs.
Khongkow P; Middleton AW; Wong JP; Kandola NK; Kongsema M; de Moraes GN; Gomes AR; Lam EW
Methods Mol Biol; 2016; 1395():39-53. PubMed ID: 26910067
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.
Khongkow P; Karunarathna U; Khongkow M; Gong C; Gomes AR; Yagüe E; Monteiro LJ; Kongsema M; Zona S; Man EP; Tsang JW; Coombes RC; Wu KJ; Khoo US; Medema RH; Freire R; Lam EW
Oncogene; 2014 Aug; 33(32):4144-55. PubMed ID: 24141789
[TBL] [Abstract][Full Text] [Related]
3. Assays on DNA Damage and Repair in CLL.
Lai TH; Sampath D
Methods Mol Biol; 2019; 1881():153-163. PubMed ID: 30350204
[TBL] [Abstract][Full Text] [Related]
4. The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment.
Monteiro LJ; Khongkow P; Kongsema M; Morris JR; Man C; Weekes D; Koo CY; Gomes AR; Pinto PH; Varghese V; Kenny LM; Charles Coombes R; Freire R; Medema RH; Lam EW
Oncogene; 2013 Sep; 32(39):4634-45. PubMed ID: 23108394
[TBL] [Abstract][Full Text] [Related]
5. The Arf/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugs.
Atsumi Y; Inase A; Osawa T; Sugihara E; Sakasai R; Fujimori H; Teraoka H; Saya H; Kanno M; Tashiro F; Nakagama H; Masutani M; Yoshioka K
J Biol Chem; 2013 May; 288(19):13269-77. PubMed ID: 23536184
[TBL] [Abstract][Full Text] [Related]
6. [The role of DNA double strains damage repairing mechanisms in high glucose-induced endothelial senescence].
Xu TY; Ding QF; Wan ZH; Zeng L; Chang BB; Zhang XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):190-3, 198. PubMed ID: 21500551
[TBL] [Abstract][Full Text] [Related]
7. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M
Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762
[TBL] [Abstract][Full Text] [Related]
8. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation.
Wagner W; Ciszewski WM; Kania KD
Cell Commun Signal; 2015 Jul; 13():36. PubMed ID: 26208712
[TBL] [Abstract][Full Text] [Related]
9. Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance.
Nestal de Moraes G; Bella L; Zona S; Burton MJ; Lam EW
Curr Drug Targets; 2016; 17(2):164-77. PubMed ID: 25418858
[TBL] [Abstract][Full Text] [Related]
10. The comet assay: a sensitive genotoxicity test for the detection of DNA damage and repair.
Speit G; Rothfuss A
Methods Mol Biol; 2012; 920():79-90. PubMed ID: 22941597
[TBL] [Abstract][Full Text] [Related]
11. Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response.
Cha H; Lowe JM; Li H; Lee JS; Belova GI; Bulavin DV; Fornace AJ
Cancer Res; 2010 May; 70(10):4112-22. PubMed ID: 20460517
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of H2AX phosphorylation after exposure to cisplatin.
Olive PL; Banáth JP
Cytometry B Clin Cytom; 2009 Mar; 76(2):79-90. PubMed ID: 18727058
[TBL] [Abstract][Full Text] [Related]
13. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation.
Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM
Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884
[TBL] [Abstract][Full Text] [Related]
14. The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells.
Wilson AJ; Holson E; Wagner F; Zhang YL; Fass DM; Haggarty SJ; Bhaskara S; Hiebert SW; Schreiber SL; Khabele D
Cancer Biol Ther; 2011 Sep; 12(6):484-93. PubMed ID: 21738006
[TBL] [Abstract][Full Text] [Related]
15. The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis.
Rebbaa A; Zheng X; Chu F; Mirkin BL
Cell Death Differ; 2006 Nov; 13(11):1960-7. PubMed ID: 16557274
[TBL] [Abstract][Full Text] [Related]
16. Detecting Markers of Therapy-Induced Senescence in Cancer Cells.
Fan DN; Schmitt CA
Methods Mol Biol; 2017; 1534():41-52. PubMed ID: 27812866
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic Stress-Induced Senescence.
Fan DNY; Schmitt CA
Methods Mol Biol; 2019; 1896():93-105. PubMed ID: 30474843
[TBL] [Abstract][Full Text] [Related]
18. Combining fluorescent in situ hybridization with the comet assay for targeted examination of DNA damage and repair.
Shaposhnikov S; Thomsen PD; Collins AR
Methods Mol Biol; 2011; 682():115-32. PubMed ID: 21057925
[TBL] [Abstract][Full Text] [Related]
19. Assessment of in vivo genotoxicity of the rodent carcinogen furan: evaluation of DNA damage and induction of micronuclei in mouse splenocytes.
Leopardi P; Cordelli E; Villani P; Cremona TP; Conti L; De Luca G; Crebelli R
Mutagenesis; 2010 Jan; 25(1):57-62. PubMed ID: 19850624
[TBL] [Abstract][Full Text] [Related]
20. Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells.
Minieri V; Saviozzi S; Gambarotta G; Lo Iacono M; Accomasso L; Cibrario Rocchietti E; Gallina C; Turinetto V; Giachino C
J Cell Mol Med; 2015 Apr; 19(4):734-43. PubMed ID: 25619736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
